FDA Panel Backs Vertex Pharmaceuticals (VRTX) Telaprevir
Tweet
Share
E-mailGet Alerts VRTX Hot Sheet
Join SI Premium – FREE
FDA panel vote 18-0 to back Vertex Pharmaceuticals (Nasdaq: VRTX) telaprevir. Shares have been halted since this morning.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Hunterbrook bullish on Modine Manufacturing (MOD)
- Broadcom said to seek over $60B in latest AI debt deal
- Citigroup set to join top banks in Anthropic IPO - Bloomberg
Create E-mail Alert Related Categories
FDA, Hot FDA News, Trader Talk, Trading HaltsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
